Global Non-prescription Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Non-prescription Drugs market size was valued at USD 128780 million in 2023 and is forecast to a readjusted size of USD 184410 million by 2030 with a CAGR of 5.3% during review period.
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Non-prescription Drugs industry chain, the market status of Hospital (Brand Drugs, Generic Drug), Clinic (Brand Drugs, Generic Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-prescription Drugs.
Regionally, the report analyzes the Non-prescription Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-prescription Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-prescription Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-prescription Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Brand Drugs, Generic Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-prescription Drugs market.
Regional Analysis: The report involves examining the Non-prescription Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-prescription Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-prescription Drugs:
Company Analysis: Report covers individual Non-prescription Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-prescription Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Non-prescription Drugs. It assesses the current state, advancements, and potential future developments in Non-prescription Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-prescription Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-prescription Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Non-prescription Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-prescription Drugs, with revenue, gross margin and global market share of Non-prescription Drugs from 2019 to 2024.
Chapter 3, the Non-prescription Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-prescription Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-prescription Drugs.
Chapter 13, to describe Non-prescription Drugs research findings and conclusion.
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Non-prescription Drugs industry chain, the market status of Hospital (Brand Drugs, Generic Drug), Clinic (Brand Drugs, Generic Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-prescription Drugs.
Regionally, the report analyzes the Non-prescription Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-prescription Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Non-prescription Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-prescription Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Brand Drugs, Generic Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-prescription Drugs market.
Regional Analysis: The report involves examining the Non-prescription Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-prescription Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Non-prescription Drugs:
Company Analysis: Report covers individual Non-prescription Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-prescription Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Non-prescription Drugs. It assesses the current state, advancements, and potential future developments in Non-prescription Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-prescription Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Non-prescription Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Brand Drugs
- Generic Drug
- Hospital
- Clinic
- Other
- Pfizer
- Roche
- Sanofi
- Johnson & Johnson
- Merck & Co. (MSD)
- Novartis
- AbbVie
- Gilead Sciences
- GlaxoSmithKline (GSK)
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Teva
- Bayer
- Novo Nordisk
- AbbVie
- Takeda
- Boehringer Ingelheim
- Takeda
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-prescription Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-prescription Drugs, with revenue, gross margin and global market share of Non-prescription Drugs from 2019 to 2024.
Chapter 3, the Non-prescription Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Non-prescription Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-prescription Drugs.
Chapter 13, to describe Non-prescription Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-prescription Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-prescription Drugs by Type
1.3.1 Overview: Global Non-prescription Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-prescription Drugs Consumption Value Market Share by Type in 2023
1.3.3 Brand Drugs
1.3.4 Generic Drug
1.4 Global Non-prescription Drugs Market by Application
1.4.1 Overview: Global Non-prescription Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-prescription Drugs Market Size & Forecast
1.6 Global Non-prescription Drugs Market Size and Forecast by Region
1.6.1 Global Non-prescription Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-prescription Drugs Market Size by Region, (2019-2030)
1.6.3 North America Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-prescription Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Non-prescription Drugs Product and Solutions
2.1.4 Pfizer Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-prescription Drugs Product and Solutions
2.2.4 Roche Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Non-prescription Drugs Product and Solutions
2.3.4 Sanofi Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Non-prescription Drugs Product and Solutions
2.4.4 Johnson & Johnson Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Non-prescription Drugs Product and Solutions
2.5.4 Merck & Co. (MSD) Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck & Co. (MSD) Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-prescription Drugs Product and Solutions
2.6.4 Novartis Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Non-prescription Drugs Product and Solutions
2.7.4 AbbVie Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Non-prescription Drugs Product and Solutions
2.8.4 Gilead Sciences Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Gilead Sciences Recent Developments and Future Plans
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product and Solutions
2.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GlaxoSmithKline (GSK) Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Non-prescription Drugs Product and Solutions
2.10.4 Amgen Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Amgen Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Non-prescription Drugs Product and Solutions
2.11.4 AstraZeneca Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Non-prescription Drugs Product and Solutions
2.12.4 Bristol-Myers Squibb Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Non-prescription Drugs Product and Solutions
2.13.4 Eli Lilly Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Non-prescription Drugs Product and Solutions
2.14.4 Teva Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Teva Recent Developments and Future Plans
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Non-prescription Drugs Product and Solutions
2.15.4 Bayer Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Bayer Recent Developments and Future Plans
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Non-prescription Drugs Product and Solutions
2.16.4 Novo Nordisk Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novo Nordisk Recent Developments and Future Plans
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business
2.17.3 AbbVie Non-prescription Drugs Product and Solutions
2.17.4 AbbVie Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 AbbVie Recent Developments and Future Plans
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Non-prescription Drugs Product and Solutions
2.18.4 Takeda Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Takeda Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-prescription Drugs Product and Solutions
2.19.4 Boehringer Ingelheim Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Non-prescription Drugs Product and Solutions
2.20.4 Takeda Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-prescription Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-prescription Drugs by Company Revenue
3.2.2 Top 3 Non-prescription Drugs Players Market Share in 2023
3.2.3 Top 6 Non-prescription Drugs Players Market Share in 2023
3.3 Non-prescription Drugs Market: Overall Company Footprint Analysis
3.3.1 Non-prescription Drugs Market: Region Footprint
3.3.2 Non-prescription Drugs Market: Company Product Type Footprint
3.3.3 Non-prescription Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-prescription Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-prescription Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-prescription Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-prescription Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-prescription Drugs Consumption Value by Type (2019-2030)
6.2 North America Non-prescription Drugs Consumption Value by Application (2019-2030)
6.3 North America Non-prescription Drugs Market Size by Country
6.3.1 North America Non-prescription Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Non-prescription Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Non-prescription Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-prescription Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-prescription Drugs Consumption Value by Type (2019-2030)
7.2 Europe Non-prescription Drugs Consumption Value by Application (2019-2030)
7.3 Europe Non-prescription Drugs Market Size by Country
7.3.1 Europe Non-prescription Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.3 France Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Non-prescription Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-prescription Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-prescription Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-prescription Drugs Market Size by Region
8.3.1 Asia-Pacific Non-prescription Drugs Consumption Value by Region (2019-2030)
8.3.2 China Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.5 India Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Non-prescription Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-prescription Drugs Consumption Value by Type (2019-2030)
9.2 South America Non-prescription Drugs Consumption Value by Application (2019-2030)
9.3 South America Non-prescription Drugs Market Size by Country
9.3.1 South America Non-prescription Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-prescription Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-prescription Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-prescription Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-prescription Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-prescription Drugs Market Size by Country
10.3.1 Middle East & Africa Non-prescription Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-prescription Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-prescription Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Non-prescription Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-prescription Drugs Market Drivers
11.2 Non-prescription Drugs Market Restraints
11.3 Non-prescription Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-prescription Drugs Industry Chain
12.2 Non-prescription Drugs Upstream Analysis
12.3 Non-prescription Drugs Midstream Analysis
12.4 Non-prescription Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-prescription Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-prescription Drugs by Type
1.3.1 Overview: Global Non-prescription Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Non-prescription Drugs Consumption Value Market Share by Type in 2023
1.3.3 Brand Drugs
1.3.4 Generic Drug
1.4 Global Non-prescription Drugs Market by Application
1.4.1 Overview: Global Non-prescription Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-prescription Drugs Market Size & Forecast
1.6 Global Non-prescription Drugs Market Size and Forecast by Region
1.6.1 Global Non-prescription Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Non-prescription Drugs Market Size by Region, (2019-2030)
1.6.3 North America Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Non-prescription Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Non-prescription Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Non-prescription Drugs Product and Solutions
2.1.4 Pfizer Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-prescription Drugs Product and Solutions
2.2.4 Roche Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Non-prescription Drugs Product and Solutions
2.3.4 Sanofi Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Non-prescription Drugs Product and Solutions
2.4.4 Johnson & Johnson Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Merck & Co. (MSD)
2.5.1 Merck & Co. (MSD) Details
2.5.2 Merck & Co. (MSD) Major Business
2.5.3 Merck & Co. (MSD) Non-prescription Drugs Product and Solutions
2.5.4 Merck & Co. (MSD) Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck & Co. (MSD) Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-prescription Drugs Product and Solutions
2.6.4 Novartis Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Non-prescription Drugs Product and Solutions
2.7.4 AbbVie Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business
2.8.3 Gilead Sciences Non-prescription Drugs Product and Solutions
2.8.4 Gilead Sciences Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Gilead Sciences Recent Developments and Future Plans
2.9 GlaxoSmithKline (GSK)
2.9.1 GlaxoSmithKline (GSK) Details
2.9.2 GlaxoSmithKline (GSK) Major Business
2.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product and Solutions
2.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GlaxoSmithKline (GSK) Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Non-prescription Drugs Product and Solutions
2.10.4 Amgen Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Amgen Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Non-prescription Drugs Product and Solutions
2.11.4 AstraZeneca Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Non-prescription Drugs Product and Solutions
2.12.4 Bristol-Myers Squibb Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business
2.13.3 Eli Lilly Non-prescription Drugs Product and Solutions
2.13.4 Eli Lilly Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Eli Lilly Recent Developments and Future Plans
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business
2.14.3 Teva Non-prescription Drugs Product and Solutions
2.14.4 Teva Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Teva Recent Developments and Future Plans
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Non-prescription Drugs Product and Solutions
2.15.4 Bayer Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Bayer Recent Developments and Future Plans
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business
2.16.3 Novo Nordisk Non-prescription Drugs Product and Solutions
2.16.4 Novo Nordisk Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novo Nordisk Recent Developments and Future Plans
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business
2.17.3 AbbVie Non-prescription Drugs Product and Solutions
2.17.4 AbbVie Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 AbbVie Recent Developments and Future Plans
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Non-prescription Drugs Product and Solutions
2.18.4 Takeda Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Takeda Recent Developments and Future Plans
2.19 Boehringer Ingelheim
2.19.1 Boehringer Ingelheim Details
2.19.2 Boehringer Ingelheim Major Business
2.19.3 Boehringer Ingelheim Non-prescription Drugs Product and Solutions
2.19.4 Boehringer Ingelheim Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Boehringer Ingelheim Recent Developments and Future Plans
2.20 Takeda
2.20.1 Takeda Details
2.20.2 Takeda Major Business
2.20.3 Takeda Non-prescription Drugs Product and Solutions
2.20.4 Takeda Non-prescription Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Takeda Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-prescription Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Non-prescription Drugs by Company Revenue
3.2.2 Top 3 Non-prescription Drugs Players Market Share in 2023
3.2.3 Top 6 Non-prescription Drugs Players Market Share in 2023
3.3 Non-prescription Drugs Market: Overall Company Footprint Analysis
3.3.1 Non-prescription Drugs Market: Region Footprint
3.3.2 Non-prescription Drugs Market: Company Product Type Footprint
3.3.3 Non-prescription Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-prescription Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Non-prescription Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-prescription Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Non-prescription Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Non-prescription Drugs Consumption Value by Type (2019-2030)
6.2 North America Non-prescription Drugs Consumption Value by Application (2019-2030)
6.3 North America Non-prescription Drugs Market Size by Country
6.3.1 North America Non-prescription Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Non-prescription Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Non-prescription Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Non-prescription Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Non-prescription Drugs Consumption Value by Type (2019-2030)
7.2 Europe Non-prescription Drugs Consumption Value by Application (2019-2030)
7.3 Europe Non-prescription Drugs Market Size by Country
7.3.1 Europe Non-prescription Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.3 France Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Non-prescription Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Non-prescription Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-prescription Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Non-prescription Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Non-prescription Drugs Market Size by Region
8.3.1 Asia-Pacific Non-prescription Drugs Consumption Value by Region (2019-2030)
8.3.2 China Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.5 India Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Non-prescription Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Non-prescription Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Non-prescription Drugs Consumption Value by Type (2019-2030)
9.2 South America Non-prescription Drugs Consumption Value by Application (2019-2030)
9.3 South America Non-prescription Drugs Market Size by Country
9.3.1 South America Non-prescription Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Non-prescription Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Non-prescription Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-prescription Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Non-prescription Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Non-prescription Drugs Market Size by Country
10.3.1 Middle East & Africa Non-prescription Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Non-prescription Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Non-prescription Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Non-prescription Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Non-prescription Drugs Market Drivers
11.2 Non-prescription Drugs Market Restraints
11.3 Non-prescription Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-prescription Drugs Industry Chain
12.2 Non-prescription Drugs Upstream Analysis
12.3 Non-prescription Drugs Midstream Analysis
12.4 Non-prescription Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-prescription Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-prescription Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-prescription Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Non-prescription Drugs Product and Solutions
Table 8. Pfizer Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Non-prescription Drugs Product and Solutions
Table 13. Roche Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Non-prescription Drugs Product and Solutions
Table 18. Sanofi Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Non-prescription Drugs Product and Solutions
Table 23. Johnson & Johnson Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Merck & Co. (MSD) Company Information, Head Office, and Major Competitors
Table 26. Merck & Co. (MSD) Major Business
Table 27. Merck & Co. (MSD) Non-prescription Drugs Product and Solutions
Table 28. Merck & Co. (MSD) Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Merck & Co. (MSD) Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Non-prescription Drugs Product and Solutions
Table 33. Novartis Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Novartis Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Non-prescription Drugs Product and Solutions
Table 38. AbbVie Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 41. Gilead Sciences Major Business
Table 42. Gilead Sciences Non-prescription Drugs Product and Solutions
Table 43. Gilead Sciences Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Gilead Sciences Recent Developments and Future Plans
Table 45. GlaxoSmithKline (GSK) Company Information, Head Office, and Major Competitors
Table 46. GlaxoSmithKline (GSK) Major Business
Table 47. GlaxoSmithKline (GSK) Non-prescription Drugs Product and Solutions
Table 48. GlaxoSmithKline (GSK) Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GlaxoSmithKline (GSK) Recent Developments and Future Plans
Table 50. Amgen Company Information, Head Office, and Major Competitors
Table 51. Amgen Major Business
Table 52. Amgen Non-prescription Drugs Product and Solutions
Table 53. Amgen Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Amgen Recent Developments and Future Plans
Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
Table 56. AstraZeneca Major Business
Table 57. AstraZeneca Non-prescription Drugs Product and Solutions
Table 58. AstraZeneca Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. AstraZeneca Recent Developments and Future Plans
Table 60. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 61. Bristol-Myers Squibb Major Business
Table 62. Bristol-Myers Squibb Non-prescription Drugs Product and Solutions
Table 63. Bristol-Myers Squibb Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Bristol-Myers Squibb Recent Developments and Future Plans
Table 65. Eli Lilly Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly Major Business
Table 67. Eli Lilly Non-prescription Drugs Product and Solutions
Table 68. Eli Lilly Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Recent Developments and Future Plans
Table 70. Teva Company Information, Head Office, and Major Competitors
Table 71. Teva Major Business
Table 72. Teva Non-prescription Drugs Product and Solutions
Table 73. Teva Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Teva Recent Developments and Future Plans
Table 75. Bayer Company Information, Head Office, and Major Competitors
Table 76. Bayer Major Business
Table 77. Bayer Non-prescription Drugs Product and Solutions
Table 78. Bayer Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Bayer Recent Developments and Future Plans
Table 80. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 81. Novo Nordisk Major Business
Table 82. Novo Nordisk Non-prescription Drugs Product and Solutions
Table 83. Novo Nordisk Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novo Nordisk Recent Developments and Future Plans
Table 85. AbbVie Company Information, Head Office, and Major Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie Non-prescription Drugs Product and Solutions
Table 88. AbbVie Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. AbbVie Recent Developments and Future Plans
Table 90. Takeda Company Information, Head Office, and Major Competitors
Table 91. Takeda Major Business
Table 92. Takeda Non-prescription Drugs Product and Solutions
Table 93. Takeda Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Takeda Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-prescription Drugs Product and Solutions
Table 98. Boehringer Ingelheim Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Takeda Company Information, Head Office, and Major Competitors
Table 101. Takeda Major Business
Table 102. Takeda Non-prescription Drugs Product and Solutions
Table 103. Takeda Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Recent Developments and Future Plans
Table 105. Global Non-prescription Drugs Revenue (USD Million) by Players (2019-2024)
Table 106. Global Non-prescription Drugs Revenue Share by Players (2019-2024)
Table 107. Breakdown of Non-prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Non-prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Non-prescription Drugs Players
Table 110. Non-prescription Drugs Market: Company Product Type Footprint
Table 111. Non-prescription Drugs Market: Company Product Application Footprint
Table 112. Non-prescription Drugs New Market Entrants and Barriers to Market Entry
Table 113. Non-prescription Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Non-prescription Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Non-prescription Drugs Consumption Value Share by Type (2019-2024)
Table 116. Global Non-prescription Drugs Consumption Value Forecast by Type (2025-2030)
Table 117. Global Non-prescription Drugs Consumption Value by Application (2019-2024)
Table 118. Global Non-prescription Drugs Consumption Value Forecast by Application (2025-2030)
Table 119. North America Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Non-prescription Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Non-prescription Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Non-prescription Drugs Raw Material
Table 150. Key Suppliers of Non-prescription Drugs Raw Materials
Table 1. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Non-prescription Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Non-prescription Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Non-prescription Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Non-prescription Drugs Product and Solutions
Table 8. Pfizer Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Non-prescription Drugs Product and Solutions
Table 13. Roche Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Sanofi Company Information, Head Office, and Major Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Non-prescription Drugs Product and Solutions
Table 18. Sanofi Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Sanofi Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Non-prescription Drugs Product and Solutions
Table 23. Johnson & Johnson Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Merck & Co. (MSD) Company Information, Head Office, and Major Competitors
Table 26. Merck & Co. (MSD) Major Business
Table 27. Merck & Co. (MSD) Non-prescription Drugs Product and Solutions
Table 28. Merck & Co. (MSD) Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Merck & Co. (MSD) Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Non-prescription Drugs Product and Solutions
Table 33. Novartis Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Novartis Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Non-prescription Drugs Product and Solutions
Table 38. AbbVie Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 41. Gilead Sciences Major Business
Table 42. Gilead Sciences Non-prescription Drugs Product and Solutions
Table 43. Gilead Sciences Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Gilead Sciences Recent Developments and Future Plans
Table 45. GlaxoSmithKline (GSK) Company Information, Head Office, and Major Competitors
Table 46. GlaxoSmithKline (GSK) Major Business
Table 47. GlaxoSmithKline (GSK) Non-prescription Drugs Product and Solutions
Table 48. GlaxoSmithKline (GSK) Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. GlaxoSmithKline (GSK) Recent Developments and Future Plans
Table 50. Amgen Company Information, Head Office, and Major Competitors
Table 51. Amgen Major Business
Table 52. Amgen Non-prescription Drugs Product and Solutions
Table 53. Amgen Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Amgen Recent Developments and Future Plans
Table 55. AstraZeneca Company Information, Head Office, and Major Competitors
Table 56. AstraZeneca Major Business
Table 57. AstraZeneca Non-prescription Drugs Product and Solutions
Table 58. AstraZeneca Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. AstraZeneca Recent Developments and Future Plans
Table 60. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 61. Bristol-Myers Squibb Major Business
Table 62. Bristol-Myers Squibb Non-prescription Drugs Product and Solutions
Table 63. Bristol-Myers Squibb Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Bristol-Myers Squibb Recent Developments and Future Plans
Table 65. Eli Lilly Company Information, Head Office, and Major Competitors
Table 66. Eli Lilly Major Business
Table 67. Eli Lilly Non-prescription Drugs Product and Solutions
Table 68. Eli Lilly Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Recent Developments and Future Plans
Table 70. Teva Company Information, Head Office, and Major Competitors
Table 71. Teva Major Business
Table 72. Teva Non-prescription Drugs Product and Solutions
Table 73. Teva Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Teva Recent Developments and Future Plans
Table 75. Bayer Company Information, Head Office, and Major Competitors
Table 76. Bayer Major Business
Table 77. Bayer Non-prescription Drugs Product and Solutions
Table 78. Bayer Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Bayer Recent Developments and Future Plans
Table 80. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 81. Novo Nordisk Major Business
Table 82. Novo Nordisk Non-prescription Drugs Product and Solutions
Table 83. Novo Nordisk Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novo Nordisk Recent Developments and Future Plans
Table 85. AbbVie Company Information, Head Office, and Major Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie Non-prescription Drugs Product and Solutions
Table 88. AbbVie Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. AbbVie Recent Developments and Future Plans
Table 90. Takeda Company Information, Head Office, and Major Competitors
Table 91. Takeda Major Business
Table 92. Takeda Non-prescription Drugs Product and Solutions
Table 93. Takeda Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Takeda Recent Developments and Future Plans
Table 95. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 96. Boehringer Ingelheim Major Business
Table 97. Boehringer Ingelheim Non-prescription Drugs Product and Solutions
Table 98. Boehringer Ingelheim Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Recent Developments and Future Plans
Table 100. Takeda Company Information, Head Office, and Major Competitors
Table 101. Takeda Major Business
Table 102. Takeda Non-prescription Drugs Product and Solutions
Table 103. Takeda Non-prescription Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Recent Developments and Future Plans
Table 105. Global Non-prescription Drugs Revenue (USD Million) by Players (2019-2024)
Table 106. Global Non-prescription Drugs Revenue Share by Players (2019-2024)
Table 107. Breakdown of Non-prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Non-prescription Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 109. Head Office of Key Non-prescription Drugs Players
Table 110. Non-prescription Drugs Market: Company Product Type Footprint
Table 111. Non-prescription Drugs Market: Company Product Application Footprint
Table 112. Non-prescription Drugs New Market Entrants and Barriers to Market Entry
Table 113. Non-prescription Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Non-prescription Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 115. Global Non-prescription Drugs Consumption Value Share by Type (2019-2024)
Table 116. Global Non-prescription Drugs Consumption Value Forecast by Type (2025-2030)
Table 117. Global Non-prescription Drugs Consumption Value by Application (2019-2024)
Table 118. Global Non-prescription Drugs Consumption Value Forecast by Application (2025-2030)
Table 119. North America Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 120. North America Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 121. North America Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 122. North America Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 123. North America Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 124. North America Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 125. Europe Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 126. Europe Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 127. Europe Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 128. Europe Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 129. Europe Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 130. Europe Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 131. Asia-Pacific Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 132. Asia-Pacific Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 133. Asia-Pacific Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 134. Asia-Pacific Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 135. Asia-Pacific Non-prescription Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Asia-Pacific Non-prescription Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 137. South America Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 138. South America Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 139. South America Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 140. South America Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 141. South America Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa Non-prescription Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 144. Middle East & Africa Non-prescription Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 145. Middle East & Africa Non-prescription Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 146. Middle East & Africa Non-prescription Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 147. Middle East & Africa Non-prescription Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 148. Middle East & Africa Non-prescription Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 149. Non-prescription Drugs Raw Material
Table 150. Key Suppliers of Non-prescription Drugs Raw Materials
LIST OF FIGURES
Figure 1. Non-prescription Drugs Picture
Figure 2. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-prescription Drugs Consumption Value Market Share by Type in 2023
Figure 4. Brand Drugs
Figure 5. Generic Drug
Figure 6. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-prescription Drugs Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Non-prescription Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Non-prescription Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Non-prescription Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Non-prescription Drugs Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Non-prescription Drugs Consumption Value Market Share by Region in 2023
Figure 16. North America Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Non-prescription Drugs Revenue Share by Players in 2023
Figure 22. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Non-prescription Drugs Market Share in 2023
Figure 24. Global Top 6 Players Non-prescription Drugs Market Share in 2023
Figure 25. Global Non-prescription Drugs Consumption Value Share by Type (2019-2024)
Figure 26. Global Non-prescription Drugs Market Share Forecast by Type (2025-2030)
Figure 27. Global Non-prescription Drugs Consumption Value Share by Application (2019-2024)
Figure 28. Global Non-prescription Drugs Market Share Forecast by Application (2025-2030)
Figure 29. North America Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. France Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Region (2019-2030)
Figure 46. China Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. India Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Non-prescription Drugs Market Drivers
Figure 64. Non-prescription Drugs Market Restraints
Figure 65. Non-prescription Drugs Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2023
Figure 68. Manufacturing Process Analysis of Non-prescription Drugs
Figure 69. Non-prescription Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Non-prescription Drugs Picture
Figure 2. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Non-prescription Drugs Consumption Value Market Share by Type in 2023
Figure 4. Brand Drugs
Figure 5. Generic Drug
Figure 6. Global Non-prescription Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Non-prescription Drugs Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Non-prescription Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Non-prescription Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Non-prescription Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Non-prescription Drugs Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Non-prescription Drugs Consumption Value Market Share by Region in 2023
Figure 16. North America Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Non-prescription Drugs Revenue Share by Players in 2023
Figure 22. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Non-prescription Drugs Market Share in 2023
Figure 24. Global Top 6 Players Non-prescription Drugs Market Share in 2023
Figure 25. Global Non-prescription Drugs Consumption Value Share by Type (2019-2024)
Figure 26. Global Non-prescription Drugs Market Share Forecast by Type (2025-2030)
Figure 27. Global Non-prescription Drugs Consumption Value Share by Application (2019-2024)
Figure 28. Global Non-prescription Drugs Market Share Forecast by Application (2025-2030)
Figure 29. North America Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. France Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Non-prescription Drugs Consumption Value Market Share by Region (2019-2030)
Figure 46. China Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. India Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Non-prescription Drugs Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Non-prescription Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Non-prescription Drugs Market Drivers
Figure 64. Non-prescription Drugs Market Restraints
Figure 65. Non-prescription Drugs Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2023
Figure 68. Manufacturing Process Analysis of Non-prescription Drugs
Figure 69. Non-prescription Drugs Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
